Bill Sibold, Madrigal Pharmaceuticals CEO
Madrigal says it's 'well on the way' to potential NASH launch ahead of FDA decision: #JPM24
SAN FRANCISCO — Madrigal Pharmaceuticals will be “ready to go” if the FDA grants its nonalcoholic steatohepatitis hopeful an accelerated approval in March, the company’s new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.